Page last updated: 2024-08-25

bendamustine hydrochloride and Neurolymphomatosis

bendamustine hydrochloride has been researched along with Neurolymphomatosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Aisa, Y; Ito, C; Kadota, S; Kurosawa, S; Nakayama, H; Nakazato, T; Okubo, S; Sakurai, A; Shinmura, K	1

Other Studies

1 other study(ies) available for bendamustine hydrochloride and Neurolymphomatosis

Article	Year
Polatuzumab vedotin plus bendamustine and rituximab (Pola-BR) was effective for neurolymphomatosis in a patient with refractory diffuse large B-cell lymphoma. Annals of hematology, 2023, Volume: 102, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Humans; Immunoconjugates; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Neurolymphomatosis; Rituximab	2023

Article

Year

Polatuzumab vedotin plus bendamustine and rituximab (Pola-BR) was effective for neurolymphomatosis in a patient with refractory diffuse large B-cell lymphoma.

Annals of hematology, 2023, Volume: 102, Issue:1

Topics: Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Humans; Immunoconjugates; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Neurolymphomatosis; Rituximab

2023